May 14, 2026
LL-37 Cathelicidin Peptide in Preclinical Research
Preclinical research on LL-37 cathelicidin peptide covers membrane disruption, immunomodulation, wound healing, and anti-biofilm activity in lab models.
RESEARCH NOTES
May 14, 2026
Preclinical research on LL-37 cathelicidin peptide covers membrane disruption, immunomodulation, wound healing, and anti-biofilm activity in lab models.